However, co‐localization of TMCC2 and APP immunoreactivity seen in the putative axonal dystrophies bordering amyloid plaques of late onset AD (Figure 2G,H) was not observed in the early onset AD cases examined (Figure S4). Here, TMCC2 is linked to Alzheimer disease.